GENE ONLINE|News &
Opinion
Blog

Samsung Bioepis
GeneOnline’s Weekly News Highlights: Sept 11-Sept 15
2023-09-19
Samsung Biologics Snaps Up Biogen’s Stake in Samsung Bioepis for $2.3 Billion, Assuming Full Control of Biosimilar Venture
2022-01-28
FDA Approves Samsung Bioepis and Biogen’s Lucentis Biosimilar
2021-09-22
Samsung Bioepis Presents 5-Year Follow-up Results on Trastuzumab Biosimilar at ESMO 2021
2021-09-13
South Korea’s Boryung Launches Avastin Biosimilar Developed by Samsung Bioepis
2021-09-02
Korea Made Humira Biosimilar Begins Sales in Australia, Marks its Presence in Third Overseas Market
2021-03-31
Two South Korean Companies Look to Capture the Biosimilars Market Worth Billions
2020-12-01
Weekly Cover: Acepodia’s NK Cell Therapy Drug Candidate ACE1702 Receives FDA Clearance of IND
2020-01-15
Samsung Bioepis Expects to Earn Profits for the First Time in Eight Years
2019-11-12
Weekly in Asia |Nov
2019-11-12
Weekly in Asia 2019|JUL
2019-08-02
LATEST
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top